Arkolith/Insider Trading/TCON/Form 4

Opaleye Management Inc.

10% OwnerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Nov 14, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 10, 2023Sell(S)440K$0.29$128K0
Nov 10, 2023Sell(S)4.3M$0.29$1.3M0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-041038) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML